Results 1 to 10 of about 54,631 (270)

The Radiobiology of Radiopharmaceuticals.

open access: yesSeminars in Radiation Oncology, 2021
Radiopharmaceutical therapy or targeted radionuclide therapy (TRT) is a well-established class of cancer therapeutics that includes a growing number of FDA-approved drugs and a promising pipeline of experimental therapeutics. Radiobiology is fundamental to a mechanistic understanding of the therapeutic capacity of these agents and their potential ...
Z. Morris, Andrew Z. Wang, S. Knox
semanticscholar   +4 more sources

Analysis of Radiopharmaceuticals [PDF]

open access: bronzeJournal of AOAC INTERNATIONAL, 1971
Abstract Some of the activities of chemists engaged in evaluating and selecting analytical methodology for examination of radiopharmaceuticals and the criteria for assessment of their quality are described. Significant problems, as they relate to a regulatory analysis program, and tentative solutions to these problems are discussed ...
Max Jaffee, Leonard A. Ford
openalex   +3 more sources

Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation? [PDF]

open access: yesEJNMMI Radiopharmacy and Chemistry
Background Radiopharmaceuticals have been considered a special group of medicines in Europe since 1989. The use of radiopharmaceuticals that have marketing authorization should always be the first option in clinical use, however due to their special ...
Estrella Moya   +3 more
doaj   +2 more sources

PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials

open access: yesThe Oncologist, 2023
Radiopharmaceuticals have been utilized for men with advanced prostate cancer for decades. Older agents, seldom used today, provided palliation for bone metastatic pain.
B. Ramnaraign, O. Sartor
semanticscholar   +1 more source

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade

open access: yesInternational Journal of Molecular Sciences, 2022
Positron emission tomography (PET) uses radioactive tracers and enables the functional imaging of several metabolic processes, blood flow measurements, regional chemical composition, and/or chemical absorption.
George Crișan   +5 more
semanticscholar   +1 more source

An Overview of In Vitro Assays of 64Cu-, 68Ga-, 125I-, and 99mTc-Labelled Radiopharmaceuticals Using Radiometric Counters in the Era of Radiotheranostics

open access: yesDiagnostics, 2023
Radionuclides are unstable isotopes that mainly emit alpha (α), beta (β) or gamma (γ) radiation through radiation decay. Therefore, they are used in the biomedical field to label biomolecules or drugs for diagnostic imaging applications, such as positron
V. Benfante   +14 more
semanticscholar   +1 more source

Synthesis and comparative evaluation of 177Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes

open access: yesScientific Reports, 2022
Highest global cancer incidence of female breast cancer is a matter of great concern. HER2-positive breast cancers have high mortality rate hence detection at an early stage is vital for successful treatment, improved cancer care and survival rate ...
Amit Kumar Sharma   +6 more
doaj   +1 more source

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker

open access: yesMolecules, 2022
Therapeutic radiopharmaceuticals have been researched extensively in the last decade as a result of the growing research interest in personalized medicine to improve diagnostic accuracy and intensify intensive therapy while limiting side effects ...
H. A. Holik   +5 more
semanticscholar   +1 more source

Therapy with Radiopharmaceuticals [PDF]

open access: yesActa Oncologica, 2002
In an investigation by the Swedish Cancer Society, an expert group described the present status, critical issues and future aspects and potentials for each of nine major areas of radiation therapy research. The present report deals with therapy with radiopharmaceuticals.
Jörgen, Carlsson   +4 more
openaire   +3 more sources

Preparation and Preliminary Imaging of Novel Albumin-Binding PSMA Ligand [177Lu]Lu-DOTA-CPN-PSMA

open access: yesHe huaxue yu fangshe huaxue, 2023
A novel PSMA targeting molecule [177Lu]Lu-DOTA-CPN-PSMA with high uptake and long retention in prostate cancer was developed, in which DOTA was used as the bifunctional chelator, glutamic acid-urea-lysine(Glu-Urea-Lys) was used as the targeting group ...
LUO Tian-wei   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy